Clinical Trial Update: Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating anlotinib with etoposide and platinum for extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Etoposide (Etoposide)
• Platinum (Platinum-based chemotherapy)

Snippet

Sponsor: Fudan University | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN